-
Loading metrics
Open Access
Peer-reviewed
Research Article
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
-
Martin Köbel,
Affiliations Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada , Institute of Pathology, Charité Hospital, Berlin, Germany
⨯ -
Steve E Kalloger,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Niki Boyd,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Steven McKinney,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Erika Mehl,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Chana Palmer,
Affiliation Canary Foundation, San Jose, California, United States of America
⨯ -
Samuel Leung,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Nathan J Bowen,
Affiliation School of Biology, Georgia Institute of Technology, and Ovarian Cancer Institute, Atlanta, Georgia, United States of America
⨯ -
Diana N Ionescu,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Ashish Rajput,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Leah M Prentice,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Dianne Miller,
Affiliation Department of Gynecology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Jennifer Santos,
Affiliation Cheryl Brown Ovarian Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
Kenneth Swenerton,
Affiliation Cheryl Brown Ovarian Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ -
C. Blake Gilks,
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ - [ ... ],
-
David Huntsman
*To whom correspondence should be addressed. E-mail: dhuntsma@bccancer.bc.ca
Affiliation Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
⨯ - [ view all ]
- [ view less ]
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- Martin Köbel,
- Steve E Kalloger,
- Niki Boyd,
- Steven McKinney,
- Erika Mehl,
- Chana Palmer,
- Samuel Leung,
- Nathan J Bowen,
- Diana N Ionescu,
- Ashish Rajput
- Published: December 2, 2008
- https://doi.org/10.1371/journal.pmed.0050232